Table 7.
Analyses of TCM-SSD Scores.
| Trials | Intervention (n/N) | Control (n/N) | RR [95% CI] | P value | |
|---|---|---|---|---|---|
| ZGXFD versus antihypertensive drugs | |||||
| ZGXFD versus captopril | 1 | 59/68 | 44/61 | 2.53 [1.03, 6.21] | 0.04 |
| Modified ZGXFD versus indapamide | 1 | 45/47 | 17/23 | 7.94 [1.46, 43.24] | 0.02 |
| ZGXFD versus captopril | 1 | 23/24 | 15/21 | 9.20 [1.00, 84.26] | 0.05 |
|
| |||||
| Meta-analysis | 3 | 127/139 | 76/105 | 3.78 [1.82, 7.85] | 0.0004 |
|
| |||||
| BBTD plus antihypertensive drugs versus antihypertensive drugs | |||||
| modified ZGXFD plus benazapril versus benazapril | 1 | 56/60 | 47/60 | 3.87 [1.18, 12.68] | 0.03 |
|
| |||||
| Meta-analysis | 1 | 56/60 | 47/60 | 3.87 [1.18, 12.68] | 0.03 |